Slide 1Things we knew, things we did… Things we have learnt, things we should do LIPID MANAGEMENT IN PRIMARY CARE: HOW WELL DO WE DO? Dr. Carlos Brotons Research Unit Sardenya…

Slide 1Type II Diabetes Gil C. Grimes, MD September 2006 Slide 2 Objectives Define Diagnosis of Diabetes Describe Pathogenesis Describe risk factors for Type II diabetes…

Slide 1STOP OR CONTINUE PREMEDICATION WHAT IS EVIDENCE BASED? Dr.S.Saravana babu SALEM Slide 2 PREMEDICATION REVISITED Slide 3 CHANGES IN PREMEDICANT PRESCRIPTION ARE DUE…

Slide 1Diabetic Medication Update Gil C. Grimes, MD April 2007 Slide 2 Disclaimer Not on the company dole Rarely the first to try something new Rarely the last to try something…

Slide 1TREATING LIPIDS FOR PREVENTION OF CAD : HOW AGGRESSIVE SHOULD WE BE? Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full…

Slide 1Back to the Future: Applying New Evidence in Menopause Management Michael Policar, MD, MPHwww.PolicarLectures.com Slide 2 Topics To Be Discussed New information from…

Slide 1Diabetes Complications DG van Zyl Slide 2 The Ticking Clock Slide 3 Different Diabetes Complications Macro vascular Micro vascular Neuropathy Infections Slide 4 Mechanisms…

Slide 1The ABCs of the AHA/ACC Prevention Guidelines Alessandra Calvo-Friedman, Andrew DeFilippis, MD, Ty Gluckman MD, Dominique Ashen, CRNP, PhD, Roger Blumenthal, MD, Johns…

Slide 1UPDATE IN NEPHROLOGY Christopher Valentine, MD Division of Nephrology Wexner Medical Center at The Ohio State University October 26, 2012 Slide 2 Disclosure I am the…

Slide 1Transfusion Medicine Residency Program Cases and Chapters Blood Conservation Dr. D.K. Towns June 18, 2009 Slide 2 Outline 1.Guideline Driven Blood Product Use 2. Pharmaceutical…